Liberians test Ebola vaccine
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.
The gruesome toll of West Africa’s Ebola outbreak, which has killed more than 4,200 Liberians of the more than 10,000 who have succumbed to the disease, has intensified efforts to find a vaccine for a disease that previously infected relatively few people in remote areas.
One year after the World Health Organization declared the Ebola outbreak, vaccine trials are under way in Liberia and Guinea. Sierra Leone will start a trial later this month.
In Liberia, scientists have fanned out across the country to explain the studies and reduce fear and confusion that have stymied efforts to contain Ebola.
Dr Stephen Kennedy, the Liberian lead investigator for the study, was among the first people to volunteer for the vaccine trial, getting his injection in front of the media. Similarly, in Guinea, authorities started the study by injecting a series of prominent officials, including the head of the country’s Ebola response.
The outreach worked in Liberia, where more than 700 people have volunteered, well beyond the 600 required, according to Kennedy.
“All of the reservations I have were explained, my doubts were cleared,” B. Emmanuel Lansana, a physician’s assistant who was the first person to participate in the study, said after he received his injection.
Enrollment will close soon for a Phase 2 trial, which is testing two vaccine candidates for safety and for whether they produce an immune response.
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.